WHAT WE ARE LOOKING FOR

A highly motivated scientist to contribute to the development of our next-generation liquid biopsy platform. In this role, the scientist will investigate the underlying biology of extracellular RNA in cancer. Projects may include the use of cell and organoid models, genomic screens, and biochemical methods. You will be a member of a fast-paced and creative research lab. You will also work in collaboration with Exai Bio’s computational biology team to advance our knowledge of extracellular RNA biology and its clinical applications.

WHAT YOU’LL DO

• Investigate the biology of extracellular RNA using molecular biology, cell biology and genomics.

• Design and optimize experiments to meet research lab team objectives

• Maintain clear and detailed experimental records, independently analyze and interpret data.

• Present at lab meetings, help prepare manuscripts for publication in peer-reviewed journals.

• Assist in training and supervision of new research lab team members.

WHAT YOU BRING TO THE TEAM

• PhD, MD/PhD or equivalent in molecular biology, cancer biology, genomics, or related discipline.

• Substantial track record in RNA biology and/or cancer biology. Experience in NGS method development and in cell-free RNA and/or DNA biology is a plus.

• Experience with and commitment to working as part of a multidisciplinary and collaborative team.

• Excellent communication and interpersonal skills

• You must be legally authorized to work in the U.S and be fully vaccinated against COVID-19, including all eligible booster(s), with the exception of a medical or religious exemption

WHAT YOU’LL GET AS PART OF OUR TEAM

• An inspiring working culture where our core values are more than just words on a page. We walk the talk!

• Comprehensive Benefits: medical/dental/vision, paid time off, generous holiday schedule, equity and 401k

• Additional Benefits: hybrid and remote work options, commuter benefits, home office subsidy and learning & development opportunities

WHO WE ARE

Exai Bio (exai.bio) is an early-stage diagnostic company with a powerful oncRNA and AI-based liquid biopsy platform. Our proprietary technology delivers unprecedented insight into cancer and disease biology from standard, non-invasive blood samples. We are the next generation of liquid biopsy! 

Our mission is to deliver the earliest and most accurate diagnosis of cancer. Why? Because we aspire to enable a world where cancer can be detected early, diagnosed accurately, treated in a personalized and targeted way, and ultimately cured. 

We know that people are our greatest asset and we are rapidly building a rock-star team of talent. Our people are driven by the mission, inspired by the vision of the future, and are committed to living our core values (integrity, openness, teamwork, exploration, and kindness) that connect us to our work and to one another.

WHAT WE VALUE

Our core values represent what we stand for as a team. This is what we believe in. Everyday, we strive to align our behaviors to these core values in everything we do.

INTEGRITY – Our thoughts and actions are true to science and to people. We do the right thing.

OPENNESS – We recognize and respect our differences – and embrace learning from them.

TEAMWORK – We are team players who trust and respect each other.

EXPLORATION – We are explorers, putting curiosity into action. 

KINDNESS – We are kind whenever possible – and we believe it’s always possible.

MORE ABOUT US

Exai Bio was founded with technology from the UCSF laboratory of Dr. Hani Goodarzi, and consists of veteran leaders in the RNA biology, liquid biopsy, and artificial intelligence/machine learning fields from both academia (UCSF, Stanford, MIT) and industry (Bluestar, CareDx, Evidation, Google, 23andMe, Deep Genomics). We are backed by leading life sciences and tech investors, including Section 32, Casdin Capital, and Two Sigma Ventures, who have been integral to advancing cancer diagnostics and artificial intelligence/machine learning technologies in past companies like Foundation Medicine, Thrive Earlier Detection, Insitro and Recursion.

We value a diverse, inclusive workforce and we provide equal employment opportunities for all applicants and employees. All qualified applicants will be considered without regard to an individual’s race, color, sex, gender identity, gender expression, religion, age, national origin or ancestry, citizenship, physical or mental disability, medical condition, family care status, marital status, domestic partner status, sexual orientation, genetic information, military or veteran status, or any other basis protected by federal, state or local laws. 

We do not accept unsolicited resumes from agencies or other third parties and will not pay fees associated with such resumes. Agencies, please do not send resumes to any of our locations, employees or email addresses.